Choom Signs LOI to Enter US Market Through Investment in New Jersey Cannabis Retailer
March 12 2019 - 7:15AM
InvestorsHub NewsWire
Choom Signs LOI to Enter US Market Through Investment in
New Jersey Cannabis Retailer
Vancouver, BC -- March 12,
2019 -- InvestorsHub NewsWire
-- Choom™ (CSE: CHOO) (OTCQB: CHOOF) ("Choom"), an emerging
adult and medical use cannabis company that has secured one of the
largest national retail networks in Canada, is pleased to announce
it is entering the United States, starting with the state of New
Jersey. Choom through its wholly owned US subsidiary, Choom
Holdings USA Inc., has signed a letter of intent (“LOI”) to
purchase an equity interest in a New Jersey based (the “NJ
Company”) medical retail dispensary applicant in New Jersey’s
upcoming Request of Applications (“RFA”) that also intends to enter
into recreational cannabis retail upon legalization, which is
anticipated in 2020.
The NJ Company is advancing on its retail store
strategy in New Jersey with the intention of receiving licenses to
operate the maximum allowable cannabis stores for medical and
eventually adult use when formally approved by the State.
With these licenses, the NJ Company intends to create a network of
branded stores using Choom’s medical brand, Clarity Medical
Centres, or Choom (“Choom Brands”) for its recreational retail
stores in the future. Choom will assist the NJ Company in
this highly regulated market for the buildout and operations of
cannabis retail stores. Choom will receive a royalty from the
NJ Company for the use of the Choom Brands. Choom’s
investment in the NJ Company includes pro rata rights to maintain
its equity interest on future financings.
“This is our first step into the United States,
and we are very excited for our partnership with this experienced
group to have the Choom Brands in New Jersey.” states Chris Bogart,
President & CEO of Choom Holdings Inc. “New Jersey is
home to over 9 million people currently being served by only 12
cannabis operators in its medical program. New Jersey is an
exceptional market to expand the Choom Brands. We are very
impressed with the progress they have achieved to date, and with
our expertise in cannabis retail, we are confident we can help them
successfully operate in the New Jersey market.”
The terms are not material.
Say hello to
ChoomTM
Choom™ is an emerging
adult use cannabis company that has secured one of the
largest retail networks in Canada. The Choom brand is inspired by
Hawaii's “Choom Gang”—a group of buddies in Honolulu during the
1970's who loved to smoke weed—or as the locals called
it, “Choom”. Evoking the spirit of the
original Choom Gang, our brand caters to the Canadian adult use
market with the ethos of cultivating ‘Good Times with Good
Friends’. Choom™ is focused on
delivering an elevated customer experience through our curated
retail environments, offering a diversity of brands for
Canadians across a national retail network.
“Chris Bogart”
President & CEO
Contact: Choom Holdings
Inc.
Chris
Bogart
President &
CEO
T:
604.683.2509
F:
604.683.2506
E:
chris@choom.ca
Alex
Porporo
Investor
Relations
T: 604.683.2509 Ext.
231
F:
604.683.2506
E:
alex@choom.ca
Cautionary Statement:
NEITHER THE
CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER
HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY
OF THIS RELEASE.
Forward-looking information
This news release contains forward-looking
information relating to the Company's proposed activities and other
statements that are not historical facts. Forward-looking
information relates to management's future outlook and anticipated
events or results, and include statements or information regarding
the future plans or prospects of the Company. Although management
of the Company has attempted to identify important factors that
could cause actual results to differ materially from those
contained in forward looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. These factors include risks and uncertainties associated
with regulatory approvals, changes in state or US federal laws and
policies governing medical or adult use cannabis sectors, the
results of diligence investigations, developments in the cannabis
sector, delays resulting from or inability to obtain required
regulatory approvals and ability to access sufficient capital from
internal and external sources, reliance on key personnel,
regulatory risks and delays and other risks and uncertainties
discussed in the management discussion and analysis section of the
Company's interim and most recent annual financial statement or
other reports and filings, including the Company’s Listing
Statement, made with the applicable Canadian securities regulators.
There can be no assurance that such information will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward looking
information.
Choom (CE) (USOTC:CHOOF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Choom (CE) (USOTC:CHOOF)
Historical Stock Chart
From Dec 2023 to Dec 2024